Stevenson Barcellona Occhiolino sedlis criteria Inefficiente Giocoleria Grande
Risk Stratification of <fc>Earlyâ•'Stage</fc> Cervical Cancer with <fc>Intermediateâ•'Risk</fc>
RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance
Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study
Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer. | Semantic Scholar
The pathological risk factors for early-stage cervical cancer | Download Table
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis - Gynecologic Oncology
Criterias of intermediate risk tumors: Classic vs. GOG criteria | Download Scientific Diagram
Development of a management guide wheel for cervical cancer
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study | British Journal of Cancer
Ali Saiz, MD MS on Twitter: "Great new nomogram updating Sedlis criteria + stratifying based on histology. Thanks Dr. Levinson (@HopkinsGynOnc) for reviewing this data! Important to think about DOI for SCC
Ali Saiz, MD MS on Twitter: "Great new nomogram updating Sedlis criteria + stratifying based on histology. Thanks Dr. Levinson (@HopkinsGynOnc) for reviewing this data! Important to think about DOI for SCC
Frontiers | Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria - Gynecologic Oncology
2022-RA-827-ESGO Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort | International Journal of Gynecologic Cancer
Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar
Frontiers | Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach
JCM | Free Full-Text | Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy
Frontiers | Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics –Based Nomogram
Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update? | International Journal of Gynecologic Cancer
ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort
KoreaMed Synapse
IGCS Reviews
Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB‑IIA node negative uterine cervical c
Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis - ScienceDirect